Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Change in Acquisitions & Divestments (2016 - 2020)

Historic Change in Acquisitions & Divestments for Larimar Therapeutics (LRMR) over the last 6 years, with Q1 2020 value amounting to $20.5 million.

  • Larimar Therapeutics' Change in Acquisitions & Divestments fell 4009.63% to $20.5 million in Q1 2020 from the same period last year, while for Mar 2020 it was $95.7 million, marking a year-over-year decrease of 1589.82%. This contributed to the annual value of $143.0 million for FY2024, which is 612.24% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Change in Acquisitions & Divestments of $20.5 million as of Q1 2020, which was down 4009.63% from $7.6 million recorded in Q4 2019.
  • Over the past 5 years, Larimar Therapeutics' Change in Acquisitions & Divestments peaked at $52.7 million during Q3 2016, and registered a low of $7.6 million during Q4 2019.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $34.3 million (2019), whereas its average is $34.1 million.
  • In the last 5 years, Larimar Therapeutics' Change in Acquisitions & Divestments skyrocketed by 6798.29% in 2016 and then plummeted by 7033.01% in 2019.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Change in Acquisitions & Divestments stood at $47.2 million in 2016, then fell by 19.45% to $38.0 million in 2017, then plummeted by 33.11% to $25.4 million in 2018, then tumbled by 70.33% to $7.6 million in 2019, then surged by 171.91% to $20.5 million in 2020.
  • Its Change in Acquisitions & Divestments stands at $20.5 million for Q1 2020, versus $7.6 million for Q4 2019 and $25.9 million for Q3 2019.